These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32640970)

  • 41. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.
    Nakagawa T; Saito A; Hosaka Y; Ishihara K
    Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
    Castro SA; Collighan R; Lambert PA; Dias IH; Chauhan P; Bland CE; Milic I; Milward MR; Cooper PR; Devitt A
    Cell Death Dis; 2017 Mar; 8(3):e2644. PubMed ID: 28252646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactive Gingipains from
    Glowczyk I; Wong A; Potempa B; Babyak O; Lech M; Lamont RJ; Potempa J; Koziel J
    Front Cell Infect Microbiol; 2017; 7():140. PubMed ID: 28497028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer disease.
    Sabbagh MN; Decourt B
    Expert Opin Investig Drugs; 2022 Oct; 31(10):987-993. PubMed ID: 36003033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver.
    Seyama M; Yoshida K; Yoshida K; Fujiwara N; Ono K; Eguchi T; Kawai H; Guo J; Weng Y; Haoze Y; Uchibe K; Ikegame M; Sasaki A; Nagatsuka H; Okamoto K; Okamura H; Ozaki K
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165731. PubMed ID: 32088316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.
    Benedyk M; Mydel PM; Delaleu N; Płaza K; Gawron K; Milewska A; Maresz K; Koziel J; Pyrc K; Potempa J
    J Innate Immun; 2016; 8(2):185-98. PubMed ID: 26613585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals.
    Goulet V; Britigan B; Nakayama K; Grenier D
    Infect Immun; 2004 Aug; 72(8):4351-6. PubMed ID: 15271890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor.
    Curtis MA; Aduse Opoku J; Rangarajan M; Gallagher A; Sterne JA; Reid CR; Evans HE; Samuelsson B
    Infect Immun; 2002 Dec; 70(12):6968-75. PubMed ID: 12438376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.
    Lourbakos A; Yuan YP; Jenkins AL; Travis J; Andrade-Gordon P; Santulli R; Potempa J; Pike RN
    Blood; 2001 Jun; 97(12):3790-7. PubMed ID: 11389018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.
    Nie R; Wu Z; Ni J; Zeng F; Yu W; Zhang Y; Kadowaki T; Kashiwazaki H; Teeling JL; Zhou Y
    J Alzheimers Dis; 2019; 72(2):479-494. PubMed ID: 31594220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis.
    Andrian E; Grenier D; Rouabhia M
    Infect Immun; 2004 Aug; 72(8):4689-98. PubMed ID: 15271930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Porphyromonas Gingivalis Infection Induces Synaptic Failure via Increased IL-1β Production in Leptomeningeal Cells.
    Huang W; Zeng F; Gu Y; Jiang M; Zhang X; Yan X; Kadowaki T; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    J Alzheimers Dis; 2021; 83(2):665-681. PubMed ID: 34334391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory response of uric acid produced by Porphyromonas gingivalis gingipains.
    Jun HK; An SJ; Kim HY; Choi BK
    Mol Oral Microbiol; 2020 Oct; 35(5):222-230. PubMed ID: 32794617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
    Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
    Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites.
    Imamura T; Potempa J; Pike RN; Moore JN; Barton MH; Travis J
    Infect Immun; 1995 Dec; 63(12):4877-82. PubMed ID: 7591149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    Nara PL; Sindelar D; Penn MS; Potempa J; Griffin WST
    J Alzheimers Dis; 2021; 82(4):1417-1450. PubMed ID: 34275903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and Modification of
    Hirai K; Yamaguchi-Tomikawa T; Eguchi T; Maeda H; Takashiba S
    Front Immunol; 2020; 11():1017. PubMed ID: 32582160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Porphyromonas gingivalis Infections Increase the Risk of Alzheimer's Disease: A Review.
    Fu Y; Xu X; Zhang Y; Yue P; Fan Y; Liu M; Chen J; Liu A; Zhang X; Bao F
    Oral Health Prev Dent; 2023 Jan; 21():7-16. PubMed ID: 36651311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits.
    Bryzek D; Ciaston I; Dobosz E; Gasiorek A; Makarska A; Sarna M; Eick S; Puklo M; Lech M; Potempa B; Potempa J; Koziel J
    PLoS Pathog; 2019 May; 15(5):e1007773. PubMed ID: 31107907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.